Systematic analysis of telomere length and somatic alterations in 31 cancer types

Barthel, Floris P, Wei, Wei, Tang, Ming, Martinez-Ledesma, Emmanuel, Hu, Xin, Amin, Samirkumar B, Akdemir, Kadir C, Seth, Sahil +7 more·2017·Nature Genetics
DOI 10.1038/ng.3781

Cited by (615)

Items 101–200 of 615

  1. Telomere length, telomerase reverse transcriptase promoter mutations, and melanoma risk
    P. Sivaramakrishna Rachakonda, Hai-ying Kong, Nalini Srinivas, Zaida García‐Casado, Celia Requena, Mahdi Fallah, Barbara Heidenreich, Dolores Planelles, Víctor Traves, Dirk Schadendorf et al. · 2018 · Genes Chromosomes and Cancer
  2. The complex interplay between aging and cancer
    Lucrezia A. Trastus, Fabrizio d’Adda di Fagagna · 2025 · Nature Aging
  3. Highly Aggressive Metastatic Melanoma Cells Unable to Maintain Telomere Length
    Nikenza Viceconte, Marie-Sophie Dheur, Eva Majerová, Christophe E. Pierreux, Jean‐François Baurain, Nicolas van Baren, Anabelle Decottignies · 2017 · Cell Reports
  4. Pathology and genomics of pediatric melanoma: A critical reexamination and new insights
    Armita Bahrami, Raymond L. Barnhill · 2017 · Pediatric Blood & Cancer
  5. Distinct genomic profile and specific targeted drug responses in adult cerebellar glioblastoma
    Hee Jin Cho, Junfei Zhao, Sang Won Jung, Erik Ladewig, Doo‐Sik Kong, Yeon‐Lim Suh, Yeri Lee, Donggeon Kim, Sun Hee Ahn, Mykola Bordyuh et al. · 2018 · Neuro-Oncology
  6. Regulation and clinical potential of telomerase reverse transcriptase (TERT/hTERT) in breast cancer
    Ruozhu Yang, Yi Han, Xinyu Guan, Yue Hong, Jiahao Meng, Shirong Ding, Long Qian, Wenjun Yi · 2023 · Cell Communication and Signaling
  7. Digital telomere measurement by long-read sequencing distinguishes healthy aging from disease
    Santiago E. Sanchez, Yuchao Gu, Yan Wang, Anudeep Golla, Annika Martin, William E. Shomali, Dirk F. Hockemeyer, Sharon A. Savage, Steven E. Artandi · 2024 · Nature Communications
  8. PI3Kδ Is a Therapeutic Target in Hepatocellular Carcinoma
    Eunkyong Ko, Hyun-Wook Seo, E. Jung, Soomi Ju, B. Kim, Hyeki Cho, Y. Kim, Young Min Park, Jong-Seo Kim, G. Jung · 2018 · Hepatology
  9. SERPINA3 is a key modulator of HNRNP-K transcriptional activity against oxidative stress in HCC
    Eunkyong Ko, Jong-Seo Kim, Jong Woo Bae, Jeesoo Kim, Sung-Gyoo Park, G. Jung · 2019 · Redox Biology
  10. The nuclear pore complex prevents sister chromatid recombination during replicative senescence
    Paula Aguilera, Jenna M. Whalen, Christopher Minguet, Dmitri Churikov, Catherine H. Freudenreich, Marie‐Noëlle Simon, Vincent Géli · 2020 · Nature Communications
  11. The enigma of excessively long telomeres in cancer: lessons learned from rare human POT1 variants
    Yi Gong, Amanda J. Stock, Yie Liu · 2020 · Current Opinion in Genetics & Development
  12. Genetic, Environmental and Lifestyle Determinants of Accelerated Telomere Attrition as Contributors to Risk and Severity of Multiple Sclerosis
    Michael Hecker, Jan Bühring, Brit Fitzner, Paulus Stefan Rommer, Uwe Klaus Zettl · 2021 · Biomolecules
  13. Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX
    Alexandre Tassin de Nonneville, Roger R. Reddel · 2021 · Nature Communications
  14. Telomere sequence content can be used to determine ALT activity in tumours
    Michael Lee, Erdahl Teber, Oliver Holmes, Kátia Nones, Ann‐Marie Patch, Rebecca A. Dagg, Loretta M. S. Lau, Joyce H. Y. Lee, Christine E. Napier, Jonathan W. Arthur et al. · 2018 · Nucleic Acids Research
  15. Fluorene exposure among PAH-exposed workers is associated with epigenetic markers related to lung cancer
    Ayman Alhamdow, Yona J. Essig, Annette M. Krais, Per Gustavsson, Håkan Tinnerberg, Christian H. Lindh, Jessika Hagberg, Pål Graff, María C. Albin, Karin Bröberg · 2020 · Occupational and Environmental Medicine
  16. Leukocyte telomere length in children born following blastocyst-stage embryo transfer
    Cheng Wang, Yayun Gu, Jun Ying Zhou, Jie Zang, Xiufeng Ling, Hong Li, Lingmin Hu, Bei Xu, Bo Zhang, Na Qin et al. · 2022 · Nature Medicine
  17. TERT Promoter Mutations and Telomerase in Melanoma
    Yuchen Guo, Yi Chen, Lianghui Zhang, Ling Ma, Keyu Jiang, Gang Yao, Lingjun Zhu · 2022 · Journal of Oncology
  18. Non-canonical roles of canonical telomere binding proteins in cancers
    Semih Can Akıncılar, Claire Hian Tzer Chan, Qin Feng Ng, Kerem Fidan, Vinay Tergaonkar · 2021 · Cellular and Molecular Life Sciences
  19. The relationship between telomere length and aging-related diseases
    Xuanqi Huang, Leyi Huang, Jiameng Lu, Lijuan Cheng, Du An Wu, Linmeng Li, Shuting Zhang, Xinyue Lai, Lu Xu · 2025 · Clinical and Experimental Medicine
  20. TPP1 promoter mutations cooperate with TERT promoter mutations to lengthen telomeres in melanoma
    Pattra Chun‐on, Angela M. Hinchie, Holly C. Beale, Agustin A. Gil Silva, Elizabeth A. Rush, Cindy Sander, Carla J. Connelly, Brittani K. N. Seynnaeve, John M. Kirkwood, Olena M. Vaske et al. · 2022 · Science
  21. Most large structural variants in cancer genomes can be detected without long reads
    Zi-Ning Choo, Julie M. Behr, Aditya S. Deshpande, Kevin Hadi, Xiaotong Yao, Huasong Tian, Kaori Takai, George Zakusilo, Joel A. Rosiene, Arnaud Da Cruz Paula et al. · 2023 · Nature Genetics
  22. Long-read sequencing of an advanced cancer cohort resolves rearrangements, unravels haplotypes, and reveals methylation landscapes
    Kieran O’Neill, Erin Pleasance, Jeremy Fan, Vahid Akbari, Glenn Chang, Katherine Dixon, Veronika Csizmók, Signe MacLennan, Vanessa Porter, Andrew Galbraith et al. · 2024 · Cell Genomics
  23. TERT promoter mutations in primary and secondary WHO grade III meningioma
    Andrea Daniela Maier, Adam Stenman, Fredrika Svahn, Christian Mirian, Jiri Jr Bartek, Marianne Juhler, Jan Zedenius, Helle Broholm, Tiit Illimar Mathiesen · 2020 · Brain Pathology
  24. Small-cell Carcinomas of the Urinary Bladder and Prostate: TERT Promoter Mutation Status Differentiates Sites of Malignancy and Provides Evidence of Common Clonality Between Small-cell Carcinoma of the Urinary Bladder and Urothelial Carcinoma
    David S. Priemer, Mingsheng Wang, Shaobo Zhang, Antonio Lopez-beltran B, Erik Kouba, Rodolfo Montironi, Darrell D. Davidson, Gregory T. MacLennan, Lisha Wang, Adeboye O. Osunkoya et al. · 2017 · European Urology Focus
  25. Modulation of Telomerase Activity in Cancer Cells by Dietary Compounds: A Review
    Takahiro Eitsuka, Kiyotaka Nakagawa, Shunji Kato, Junya Ito, Yurika Otoki, Soo Takasu, Naoki Shimizu, Takumi Takahashi, Teruo Miyazawa · 2018 · International Journal of Molecular Sciences
  26. ETS Factor ETV5 Activates the Mutant Telomerase Reverse Transcriptase Promoter in Thyroid Cancer
    Martyn Bullock, Grace Lim, Ying Zhu, Helena Åberg, Sergey Kurdyukov, Roderick John Clifton-Bligh · 2019 · Thyroid
  27. TERT promoter mutations and melanoma survival: A comprehensive literature review and meta-analysis
    Sara Gandini, Ines Zanna, Simone De Angelis, Domenico Palli, Sara Raimondi, Simone Ribero, Giovanna Masala, Mariano Suppa, Federica Bellerba, Federica Corso et al. · 2021 · Critical Reviews in Oncology/Hematology
  28. Regulation of telomere homeostasis and genomic stability in cancer by N 6 -adenosine methylation (m 6 A)
    Ji Hoon Lee, Juyeong Hong, Zhao Zhang, Bárbara de la Peña Avalos, Cecilia Jazmín Proietti, Agustina Roldán Deamicis, Pablo Guzmán G, Hung‐Ming Lam, José M. Garcia, Martine P. Roudier et al. · 2021 · Science Advances
  29. Τelomerase inhibitors and activators in aging and cancer: A systematic review
    Persefoni Fragkiadaki, Elisavet A. Renieri, Katerina Kalliantasi, Elisavet Kouvidi, Evita Apalaki, Elena Vakonaki, Charalampos Mamoulakis, Demetrios A. Spandidos, Aristidis Michael Tsatsakis · 2022 · Molecular Medicine Reports
  30. TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT
    Alexandre Tassin de Nonneville, Sébastien Salas, François Bertucci, Alexander P. Sobinoff, José Adélaı̈de, Arnaud Guillé, Pascal Finetti, Jane R. Noble, Dmitri Churikov, Max Chaffanet et al. · 2022 · EMBO Molecular Medicine
  31. The Role of Telomerase in Breast Cancer’s Response to Therapy
    Eliza Judasz, Natalia Lisiak, Przemysław Kopczyński, Magdalena Taube, Błażej Rubiś · 2022 · International Journal of Molecular Sciences
  32. Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications
    Irene Vanni, Enrica T. Tanda, Bruna Dalmasso, Lorenza Pastorino, Virginia Andreotti, William Bruno, Andrea Boutros, Francesco Spagnolo, Paola Ghiorzo · 2020 · Frontiers in Molecular Biosciences
  33. Telomerase as a therapeutic target in glioblastoma
    Elisa Aquilanti, Lauren Kageler, Patrick Yung Wen, Matthew M. Meyerson · 2021 · Neuro-Oncology
  34. Insights into Telomerase/hTERT Alternative Splicing Regulation Using Bioinformatics and Network Analysis in Cancer
    Andrew T. Ludlow, Aaron L. Slusher, Mohammed Sayed · 2019 · Cancers
  35. Systematic Review of Studies on Telomere Length in Patients with Multiple Sclerosis
    Jan Bühring, Michael Hecker, Brit Fitzner, Uwe Klaus Zettl · 2021 · Aging and Disease
  36. Current and Future Trends of Colorectal Cancer Treatment: Exploring Advances in Immunotherapy
    Nikolouzakis, Taxiarchis Konstantinos, Chrysos, Emmanuel, Docea, Anca Oana, Fragkiadaki, Persefoni, Souglakos, John, Tsiaoussis, John, Tsatsakis, Aristidis · 2024 · Cancers
  37. Structural variant evolution after telomere crisis
    Sally M. Dewhurst, Xiaotong Yao, Joel A. Rosiene, Huasong Tian, Julie M. Behr, Nazario Bosco, Kaori Takai, Titia de Lange, Marcin B. Imielinski · 2021 · Nature Communications
  38. TERT promoter mutations in thyroid cancer
    Michiko Matsuse, Norisato Mitsutake · 2023 · Endocrine Journal
  39. Reactivation of telomerase reverse transcriptase expression in cancer: the role of TERT promoter mutations
    Maria Lina Tornesello, Andrea Cerasuolo, Noemy Starita, Sara Amiranda, Patrizia Bonelli, Franca Maria Tuccillo, Franco M. Buonaguro, Luigi Buonaguro, Anna Lucia Tornesello · 2023 · Frontiers in Cell and Developmental Biology
  40. Precarious maintenance of simple DNA repeats in eukaryotes
    Alexander J. Neil, Jane C. Kim, Sergei M. Mirkin · 2017 · BioEssays
  41. Association of telomere length with general cognitive trajectories: a meta-analysis of four prospective cohort studies
    Yiqiang Zhan, Mark Clements, Rosebud O. Roberts, Maria E. Vassilaki, Brooke R. Druliner, Lisa A. Boardman, Ronald Carl Petersen, Chandra A. Reynolds, Nancy L. Pedersen, Sara Hägg · 2018 · Neurobiology of Aging
  42. CRISPR/Cas9-Mediated TERT Disruption in Cancer Cells
    Luan Wen, Changzhi Zhao, Jun Whi Song, Linyuan Ma, Jinxue Ruan, Xiaofeng Xia, Y. Eugene Chen, Jifeng Zhang, Peter X. Ma, Jie Xu · 2020 · International Journal of Molecular Sciences
  43. Crossroads of telomere biology and anticancer drug discovery
    H. Seimiya · 2020 · Cancer Science
  44. The Human Blood Transcriptome in a Large Population Cohort and Its Relation to Aging and Health
    Maria Schmidt, Lydia Hopp, Arsen Arakelyan, Holger Kirsten, Christoph Engel, Kerstin Wirkner, Knut Krohn, Ralph Burkhardt, Joachim Thiery, Markus Loeffler et al. · 2020 · Frontiers in Big Data
  45. Next-Generation Biomarkers in Multiple Myeloma: Understanding the Molecular Basis for Potential Use in Diagnosis and Prognosis
    Amro Mohamed Soliman, Srijit Das, Seong Lin Teoh · 2021 · International Journal of Molecular Sciences
  46. Clinical potential of circulating free DNA and circulating tumour cells in patients with metastatic non‐small‐cell lung cancer treated with pembrolizumab
    Patricia Mondelo‐Macía, Jorge García, Luis León‐Mateos, Urbano Anido, Santiago Aguín, Ihab Abdulkader, María Sánchez‐Ares, Alicia Abalo, Aitor Rodríguez‐Casanova, Ángel Díaz‐Lagares et al. · 2021 · Molecular Oncology
  47. Telomeres and Cancer
    Hueng‐Chuen Fan, Fung-Wei Chang, Jeng‐Dau Tsai, Kao‐Min Lin, Chuan‐Mu Chen, Shinn‐Zong Lin, Ching-Ann Liu, Horng‐Jyh Harn · 2021 · Life
  48. Cell Immortalization: In Vivo Molecular Bases and In Vitro Techniques for Obtention
    de Bardet, Javier Curi, Cardentey, Celeste Ramírez, González, Belkis López, Patrone, Deanira, Mulet, Idania Lores, Siniscalco, Dario, Robinson-Agramonte, María de los Angeles · 2023 · BioTech
  49. Critically short telomeres derepress retrotransposons to promote genome instability in embryonic stem cells
    Nannan Zhao, Guoxing Yin, Ryan Chun-Fu Liu, Wei-Yu Zhang, Yang Shen, Dan Wang, Zhenzhen Lin, Jiao Yang, Jian Mao, Renpeng Guo et al. · 2023 · Cell Discovery
  50. Telomerase and hallmarks of cancer: An intricate interplay governing cancer cell evolution
    Naveen Kumar, Gautam Sethi · 2023 · Cancer Letters
  51. Telomere length and cancer risk: finding Goldilocks
    Sharon A. Savage · 2023 · Biogerontology
  52. Shorter telomere length and DNA hypermethylation in peripheral blood cells of coal workers
    Melissa Rosa de Souza, Vivian Francília Silva Kahl, Paula Rohr, Kátia Kvitko, Mónica Cappetta, Wilner Martinez Lopes, Juliana da Silva · 2018 · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
  53. Telomerase and Telomeres in Endometrial Cancer
    Rafah Alnafakh, Meera Adishesh, Lucy Button, Gabriele Christine Saretzki, Dharani Kosala Hapangama · 2019 · Frontiers in Oncology
  54. Drivers underpinning the malignant transformation of giant cell tumour of bone
    Matthew W. Fittall, Iben Lyskjær, Peter Ellery, Patrick Lombard, Jannat Ijaz, Anna‐Christina Strobl, Dahmane Oukrif, Maxime Tarabichi, Martin Sill, Christian Koelsche et al. · 2020 · The Journal of Pathology
  55. The Molecular Mechanisms and Therapeutic Prospects of Alternative Lengthening of Telomeres (ALT)
    Eric J. Sohn, Julia A Goralsky, Jerry W. Shay, Jaewon Min · 2023 · Cancers
  56. Alternative lengthening of telomeres in molecular subgroups of paediatric high-grade glioma
    Simone Minasi, Caterina Baldi, Francesca Gianno, Manila Antonelli, Anna Maria Buccoliero, Torsten Pietsch, Maura Massimino, Francesca Romana Buttarelli · 2020 · Child s Nervous System
  57. Cell cycle responses to Topoisomerase II inhibition: Molecular mechanisms and clinical implications
    Tanya N. Soliman, Daniel Keifenheim, Peter J. Parker, Duncan J. Clarke · 2023 · The Journal of Cell Biology
  58. The genomics of undifferentiated sarcoma of soft tissue: Progress, challenges and opportunities
    Christopher D. Steele, Nischalan Pillay · 2019 · Seminars in Cancer Biology
  59. Spliceosome Mutations in Uveal Melanoma
    Josephine Q.N. Nguyen, Wojtek Drabarek, Serdar Yavuzyiğitoğlu, Eva Medico Salsench, Robert M. Verdijk, Nicole C. Naus, Annelies de Klein, Emine Kılıç, Erwin Brosens · 2020 · International Journal of Molecular Sciences
  60. Telomere length and survival in primary cutaneous melanoma patients
    P. Sivaramakrishna Rachakonda, Nalini Srinivas, Seyed Hamidreza Mahmoudpour, Zaida García‐Casado, Celia Requena, Víctor Traves, Virtudes Soriano, Maurizio Cardelli, Dace Pjanova, Anders Molven et al. · 2018 · Scientific Reports
  61. Tieing together loose ends: telomere instability in cancer and aging
    Gustavo de Oliveira Borges, Mélanie Criqui, Lea A. Harrington · 2022 · Molecular Oncology
  62. Interplay between TERT promoter mutations and methylation culminates in chromatin accessibility and TERT expression
    Catarina Salgado, Celine M. Roelse, Rogier J. Nell, Nelleke A. Gruis, Remco van Doorn, Pieter van der Velden · 2020 · PLoS ONE
  63. New somatic TERT promoter variants enhance the Telomerase activity in Glioblastoma
    Tiziana Pierini, Carlotta Nardelli, Anair Graciela Lema Fernandez, Valentina Pierini, Fabrizia Pellanera, Valeria Nofrini, Paolo Gorello, Martina Moretti, Silvia Arniani, Giovanni Roti et al. · 2020 · Acta Neuropathologica Communications
  64. RETRACTED ARTICLE: Telomerase gene therapy: a remission toward cancer
    Sameer Quazi · 2022 · Medical Oncology · Retracted
  65. Canine Oral Melanoma Genomic and Transcriptomic Study Defines Two Molecular Subgroups with Different Therapeutical Targets
    Anaïs Prouteau, Stéphanie Mottier, Aline Primot, Édouard Cadieu, Laura Bachelot, Nadine Botherel, Florian Cabillic, Armel Houël, Laurence Cornevin, Camille Kergal et al. · 2022 · Cancers
  66. The Molecular Interplay between Human Oncoviruses and Telomerase in Cancer Development
    Maria Lina Tornesello, Andrea Cerasuolo, Noemy Starita, Anna Lucia Tornesello, Patrizia Bonelli, Franca Maria Tuccillo, Luigi Buonaguro, Maria G. Isaguliants, Franco M. Buonaguro · 2022 · Cancers
  67. Selective and mechanistic sources of recurrent rearrangements across the cancer genome
    Jeremiah A. Wala, Ofer Shapira, Yilong Li, David Craft, Steven E. Schumacher, Marcin B. Imielinski, James E. Haber, Nicola D. Roberts, Xiaotong Yao, Chip Stewart et al. · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  68. Breakage fusion bridge cycles drive high oncogene number with moderate intratumoural heterogeneity
    Siavash R. Dehkordi, Ivy Tsz-Lo Wong, Jing Ni, Jens Luebeck, Kaiyuan Zhu, Gino Prasad, Lena Krockenberger, Guanghui Xu, Biswanath Chowdhury, Utkrisht Rajkumar et al. · 2025 · Nature Communications
  69. Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer
    Manjie Xing, Wen Fong Ooi, Jing Ying Tan, Aditi Qamra, Po-Hsien Lee, Zhimei Li, Chang Xu, Nisha Padmanabhan, Jing Quan Lim, Yu Amanda Guo et al. · 2020 · Journal of Clinical Investigation
  70. Chromothripsis and telomere crisis: engines of genome instability
    Sally M. Dewhurst · 2020 · Current Opinion in Genetics & Development
  71. Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgery
    Aurélie Moreira, Arthur Poulet, Julien Masliah‐Planchon, Charlotte Lecerf, Sophie Vacher, Linda Larbi Chérif, Célia Dupain, Grégoire Marret, Elodie Girard, Laurène Syx et al. · 2021 · ESMO Open
  72. A Modified Nucleoside 6-Thio-2′-Deoxyguanosine Exhibits Antitumor Activity in Gliomas
    Shengnan Yu, Shiyou Wei, Milan R. Savani, Xiang Lin, Kuang Du, Ilgen Mender, Silvia Siteni, Themistoklis Vasilopoulos, Zachary J. Reitman, Yin Ku et al. · 2021 · Clinical Cancer Research
  73. Telomeres, Telomerase and Cancer
    Peter M. Lansdorp · 2022 · Archives of Medical Research
  74. Telomere length variation in tumor cells and cancer‐associated fibroblasts: potential biomarker for hepatocellular carcinoma
    Lijie Ma, Xiaoying Wang, Meng Duan, Longzi Liu, Jie-Yi Shi, Liangqing Dong, Liu‐Xiao Yang, Zhichao Wang, Zhen‐Bin Ding, Ai‐Wu Ke et al. · 2017 · The Journal of Pathology
  75. Genomic and transcriptomic landscape of human gastrointestinal stromal tumors
    Feifei Xie, Shuzhen Luo, Dongbing Liu, Xiaojing Lu, Ming Wang, Xiaoxiao Liu, Fujian Jia, Yuzhi Pang, Yanying Shen, Chunling Zeng et al. · 2024 · Nature Communications
  76. The many types of heterogeneity in replicative senescence
    Zhou Xu, Maria Teresa Teixeira · 2019 · Yeast
  77. Telomeres in toxicology: Occupational health
    Mohammad Shoeb, Helen C.S. Meier, James Michael Antonini · 2020 · Pharmacology & Therapeutics
  78. Telomere Targeting Approaches in Cancer: Beyond Length Maintenance
    E. Vertecchi, A. Rizzo, E. Salvati · 2022 · International Journal of Molecular Sciences
  79. Unravelling the role of telomere shortening with ageing and their potential association with diabetes, cancer, and related lifestyle factors
    Amit Kumar Verma, Prithvi Singh, Fatimah A. Al‐Saeed, Ahmed Ezzat Ahmed, Sunil Kumar, Ashok Kumar, Kapil Dev, Ravins Dohare · 2022 · Tissue and Cell
  80. A non-genetic switch triggers alternative telomere lengthening and cellular immortalization in ATRX deficient cells
    Timothy K. Turkalo, Antonio Maffia, Johannes J. Schabort, Samuel G. Regalado, Mital S. Bhakta, Marco Blanchette, Diana C.J. Spierings, Peter M. Lansdorp, Dirk F. Hockemeyer · 2023 · Nature Communications
  81. Telomere Length Changes in Cancer: Insights on Carcinogenesis and Potential for Non-Invasive Diagnostic Strategies
    Zuzana Holesova, Lucia Krasničanová, Rami Saade, Ondrej Pös, Jaroslav Budiš, Juraj Gazdarica, Vanda Repiská, Tomáš Szemes · 2023 · Genes
  82. Tumor-Agnostic Circulating Tumor DNA Testing for Monitoring Muscle-Invasive Bladder Cancer
    Raquel Carrasco, Mercedes Ingelmo‐Torres, Ramón Trullás, Fiorella L. Roldán, Leonardo Rodríguez‐Carunchio, Lourdes Juez, Joan Sureda, Antonio Alcaraz, Lourdes Mengual, Laura Izquierdo · 2023 · International Journal of Molecular Sciences
  83. Genomic hallmarks of endocrine therapy resistance in ER/PR+HER2- breast tumours
    Arnab Ghosh, Rohan Chaubal, Chitrarpita Das, Pallavi Appa Parab, Subrata Das, Arindam Maitra, Partha Pratim Majumder, Sudeep Gupta, Nidhan K. Biswas · 2025 · Communications Biology
  84. Telomerase and Telomeres Biology in Thyroid Cancer
    Benedetta Donati, Alessia Ciarrocchi · 2019 · International Journal of Molecular Sciences
  85. Association of telomere length and telomerase methylation with n-3 fatty acids in preschool children with obesity
    Xuanyi Liu, Xiaozhou Liu, Qiaoyu Shi, Xiuqin Fan, Kemin Qi · 2021 · BMC Pediatrics
  86. Telomere Dysfunction in Chronic Lymphocytic Leukemia
    Billy Michael Chelliah Jebaraj, Stephan Stilgenbauer · 2021 · Frontiers in Oncology
  87. Telomerase-targeted therapies in myeloid malignancies
    Julian A. Waksal, Claudia Bruedigam, Rami S. Komrokji, Catriona H. M. Jamieson, John O Mascarenhas · 2023 · Blood Advances
  88. Long Noncoding RNAs in the Yeast S. cerevisiae
    Rachel O. Niederer, Evan P. Hass, David C. Zappulla · 2017 · Advances in experimental medicine and biology
  89. A pan-cancer analysis of driver gene mutations, DNA methylation and gene expressions reveals that chromatin remodeling is a major mechanism inducing global changes in cancer epigenomes
    Ahrim Youn, Kyung In Kim, Raúl Rabadán, Benjamin Tycko, Yufeng Shen, Shuang Wang · 2018 · BMC Medical Genomics
  90. Telomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics
    Songting Shou, Ayidana Maolan, Di Zhang, Xiaochen Jiang, Fudong Liu, Yi Li, Xiyuan Zhang, En Geer, Zhenqing Pu, Baojin Hua et al. · 2025 · Experimental Hematology and Oncology
  91. Mechanisms of Breast Cancer Stem Cell Specification and Self-Renewal Mediated by Hypoxia-Inducible Factor 1
    Gregg L. Semenza · 2023 · Stem Cells Translational Medicine
  92. Telomere length is greater in ALS than in controls: a whole genome sequencing study
    Ahmad Al Khleifat, Alfredo Iacoangeli, Aleksey Shatunov, Ton Fang, William Sproviero, Ashley R. Jones, Sarah Opie-Martin, Karen E. Morrison, Pamela J. Shaw, Christopher E. Shaw et al. · 2019 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
  93. Telomeres in cancer
    Çagatay Güneş, Alush I. Avila, K. Lenhard Rudolph · 2017 · Differentiation
  94. Pan-Cancer Analysis of Alternative Lengthening of Telomere Activity
    Ji‐Yong Sung, Hee‐Woong Lim, Je‐Gun Joung, Woong‐Yang Park · 2020 · Cancers
  95. Quantification of DNA methylation independent of sodium bisulfite conversion using methylation‐sensitive restriction enzymes and digital PCR
    Rogier J. Nell, Debby van Steenderen, Nino V. Menger, Thomas J. Weitering, Mieke Versluis, Pieter A. van der Velden · 2020 · Human Mutation
  96. Occurrence, functionality and abundance of the TERT promoter mutations
    Sivaramakrishna P. Rachakonda, Jörg D. Hoheisel, Rajiv Kumar · 2021 · International Journal of Cancer
  97. Analysis of Telomere Maintenance Related Genes Reveals NOP10 as a New Metastatic-Risk Marker in Pheochromocytoma/Paraganglioma
    María Monteagudo, Paula Martínez, Luis Javier Leandro-Garcia, Ángel M. Martínez‐Montes, Bruna Calsina, Marta Pulgarín-Alfaro, Alberto Díaz‐Talavera, Sara Mellid, Rocío Letón, Eduardo Gil et al. · 2021 · Cancers
  98. Telomeric Repeat-Containing RNA (TERRA): A Review of the Literature and First Assessment in Cutaneous T-Cell Lymphomas
    Alain Chebly, Joana Ropio, Lyla Baldasseroni, Martina Prochazkova‐Carlotti, Yamina Idrissi, Jacky Ferrer, Chantal Farra, Marie Beylot-Barry, Jean‐Philippe Merlio, Edith Chevret · 2022 · Genes
  99. Common genetic variations in telomere length genes and lung cancer: a Mendelian randomisation study and its novel application in lung tumour transcriptome
    Ricardo Cortez Cardoso Penha, Karl Smith‐Byrne, Joshua Atkins, Philip Haycock, Siddhartha Kar, Veryan Codd, Nilesh J. Samani, Christopher P. Nelson, Maja Milojevic, Aurélie AG Gabriel et al. · 2023 · eLife
  100. Mendelian randomization study on the causal relationship between leukocyte telomere length and prostate cancer
    Bangbei Wan, Likui Lu, Cai Lv · 2023 · PLoS ONE